Roche gets NICE approval for advanced bladder cancer
May 17, 2018Sales and Marketing Roche, biotech, drugs, pharma, pharmaceutical, tecentriq
Though trial results for Tecentriq (atezolizumab) may not necessarily be going Roche’s way, after a combination treatment failure, the treatment …
Lilly’s galcanezumab soars in episodic cluster headache, but fails in chronic form
May 16, 2018Research and Development Eli Lilly, galcanezumab, headache, migraine, pharma
Eli Lilly has released new Phase 3 results for its CGRP inhibitor galcanezumab in the treatment of episodic cluster headache, …
Novartis’ top lawyer retires from role over botched Trump deal
May 16, 2018Medical Communications, Research and Development Michael Cohen, Novartis, Trump, pharma
The saga of Novartis’ ill-advised $1.2 million deal with US President Donald Trump’s lawyer Michael Cohen continues to unfold as …
Pfizer scores approval for first Epogen/Procrit biosimilar in the US
May 16, 2018Research and Development, Sales and Marketing Epogen, Pfizer, Procrit, Retacrit, biosimilar, pharma FDA
Pfizer’s Retacrit (epoetin alfa-epbx), a biosimilar version of Amgen’s Epogen and Janssen’s Procrit, has been approved for use in the …
How to treat colds? Target the person, not the virus
May 15, 2018Research and Development biotech, common cold, drugs, pharma, pharmaceutical
Researchers from Imperial College London have discovered how to interfere with one of the building blocks that allows the common …
DIA: Pharmacovigilance conference
May 15, 2018Medical Communications, Research and Development dia
We are in the midst of a breath-taking series of changes in the world of pharmacovigilance, both within Europe and …
New cancer clinical trial model promises to cut costs and development time
May 15, 2018Manufacturing and Production, Research and Development BMS, Bristol-Myers Squibb, Cancer, MD AndersonCancer Center, clinical trials, pharma
Researchers from the University of Texas MD Anderson Cancer Center have been developing and testing a new model for the …
FDA issues warning letter over potential for poisoning at India plant
May 15, 2018Manufacturing and Production FDA, India, biotech, drugs, pharma, pharmaceutical
The FDA has noted a number of failings at a plant in Gujarat, India, but mostly significantly was the finding …
Smell test targets asymptomatic malaria carriers
May 15, 2018Manufacturing and Production, Research and Development biotech, drugs, malaria, pharma, pharmaceutical
Asymptomatic carriers of malaria may be responsible for the onwards transmission of up to 90% of cases, highlighting the importance …
Emergex secures funds in race to develop universal flu vaccine
May 15, 2018Manufacturing and Production, Sales and Marketing Emergex, Innovate UK, biotech, drugs, influenza vaccine, pharma, pharmaceutical
UK-based biotech, Emergex Vaccines, has received £1 million to push its universal flu vaccine through preclinical tests, in the hope …
Lilly chalks up another acquisition with AurKa for $575m
May 14, 2018Manufacturing and Production, Sales and Marketing AurKa, Cancer, Eli Lilly, acquisition, oncology, pharma
Swiftly following up its $1.6 billion splash to pick up Armo BioSciences last week, Eli Lilly has agreed to acquire …
Bringing the PRO to fruition
May 14, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PROs, feature, patient reported outcomes, patient-reported outcomes, pharma
Patient-reported outcomes are becoming increasingly respected and valued by clinical professionals in the pursuit of improving treatment outcomes, but their …
Medigene and bluebird bio expand immunotherapy partnership to $1.5bn
May 14, 2018Research and Development, Sales and Marketing Bluebird Bio, Cancer, Medigene, pharma
Medigene has announced that it has bolstered the existing partnership it has in place with US firm bluebird bio, originally …
Takeda financials show why the Shire deal was needed
May 14, 2018Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical
After posting its financials from 2017 and its guidance for the year to come, it’s clear to see why Takeda …
Pharma unfazed by Trump price-reduction proposals
May 14, 2018Medical Communications, Sales and Marketing PhRMA, President trump, biotech, drugs, pharma, pharmaceutical
President Trump’s speech on Friday afternoon had been long-anticipated, ever since he was elected and then hammered the pharma industry …
FDA awards first paediatric MS approval to Novartis’ Gilenya
May 14, 2018Sales and Marketing FDA, gilenya, multiple sclerosis, pharma
The FDA has awarded approval for what it says is its first drug for the treatment of multiple sclerosis (MS) …
Akari CEO resigns over allegations of spending company funds
May 11, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Akari, appointment
Akari has lost its second CEO in 12 months after David Horn Solomon was accused of misusing the company credit …
Janssen’s Tremfya gets go-ahead from NICE in plaque psoriasis
May 11, 2018Medical Communications, Sales and Marketing Janssen, NICE, Tremfya, UK, pharma, psoriasis
NICE, the UK’s drug watchdog for the NHS, has decided that Janssen’s Tremfya (guselkumab) should be used routinely through the …
Top Ten most popular articles on Pharmafile.com this week
May 11, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, EMA, GSK, J&J, JJ, Novartis, Shire, Takeda, Valeant, biotech, drugs, pharma, pharmaceutical
It’s been a week in which one of the largest pharmaceutical takeovers in history took place and yet it’s not …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
